Studies have shown that in patients with rectal cancer, gastric cancer, and pancreatic cancer, the P-CRP value is a known synergistic prognostic indicator, which is more important than CRP or platelet levels alone (7–9). The gene discussed is CRP; the disease is pancreatic neoplasm.